Role of Detoxifing Enzyme Nicotinamide Adenine Dinucleotide (Phosphate) H: Quinone Oxidoreductase-1 C609t Gene Polymorphism in Bronchogenic Carcinoma

Nermine Hossam Zakaria

Authors

Nermine Hossam Zakaria

Keywords:

Abstract

Lung cancer is currently one of the most common cancers and a major cause of cancer-related death in the world. Eighty-five percent of lung cancers are non-small cell lung cancers (NSCLCs), and 15% are small cell lung cancers (SCLCs). The most important risk factor for lung cancer is tobacco smoking. Polycyclic aromatic hydrocarbons (PAHs) are abundant in tobacco smoke and constitute a major etiological factor in lung cancer. NAD (P) H: quinone oxidore -ductase (NQO1) is a cytosolic flavoprotein that catalyzes the two-electron reduction of quinoid compounds into less toxic hydroquinones. A single base substitution (C→T) polym -orphism at 609 in the NQO1 gene reduces quinone redu -ctase activity. Published data on the association between NQO1609 C˃T polymorphism and lung cancer risk are conflicting. In this study, we investigated NQO1genotype in relation to lung cancer risk. The cases were patients attending Chest diseases unit in the Alexandria Main University Hospital with bronchogenic carcinoma in different stages. The control group consisted of age-matched male adults from the same socioeconomic class. DNA extraction from EDTA blood samples and genotyping was successfully carried out for 100 cases and 100 controls by PCR-RFLP and PCR-CTPP.

Downloads

How to Cite

Role of Detoxifing Enzyme Nicotinamide Adenine Dinucleotide (Phosphate) H: Quinone Oxidoreductase-1 C609t Gene Polymorphism in Bronchogenic Carcinoma. (2014). Global Journal of Medical Research, 14(K3), 1-8. https://medicalresearchjournal.org/index.php/GJMR/article/view/706

Download Citation

References

A Jemal, F Bray, M Center, J Ferlay, E Ward, D Forman (2011) Global cancer statistics. CA: a cancer journal for clinicians. 61, 69-90.

A Jemal, M Center, C Desantis, E Ward (2010) Global patterns of cancer incidence and mortality rates and trends. 19(8), 1893-1907.

S Spivack, G Hurteau, M Fasco, L Kaminsky (2003) Phase I and II carcinogen metabolism gene expre -ssion in human lung tissue and tumors. 9(16), 6002-6011.

P Gasdaska, G Powis, P Hyman, H Fisher (1993) Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma. 11(1-2), 123.

M Lafuente, X Casterad, M Trias, C Ascaso, R Molina, A Ballesta (2000) NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. 21(10), 1813-1819.

D Nebert, A Roe, S Vandale, E Bingham, G Oakley (2002) NAD (P) H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. 4(2), 62-70.

P Joseph, A Jaiswal (1994) NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.. 91(18), 8413-8417.

Elizabeth Rosvold, Katherine Mcgiynn, Edward Lustbader, Kenneth Buetow (1995) Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. 5(4), 199-206.

A Jaiswal (1991) Human NAD (P) H: quinone oxidoreductase (NQO1) gene structure and induction by dioxin. 30(44), 10647-10653.

P Lin, Y-M Hsueh, J-L Ko, Y-F Liang, K-J Tsai, C-Y Chen (2003) Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. 40(2), 123-129.

Sarah Lewis, Nicola Cherry, Robert Niven, Phillip Barber, Andrew Povey (2001) Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. 34(2), 177-183.

N Hamajima, T Saito, K Matsuo, K Tajima (2002) Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers. 4(2), 103-107.

Ccs Dela, L Tanoue, R Matthay (2011) Lung cancer: epidemiology, etiology, and prevention. 32(4), 605.

Donald Shopland (1995) Tobacco Use and Its Contribution to Early Cancer Mortality with a Special Emphasis on Cigarette Smoking. 103(Suppl 8), 131.

H Yu, H Liu, L-E Wang, Q Wei (2012) A functional NQO1 609C> T polymorphism and risk of gastrointestinal cancers: a meta-analysis. 7(1), 30566.

R Bu, M Gutiérrez, M Al-Rasheed, A Belgaumi, K Bhatia (2004) Variable drug metabolism genes in Arab population. 4(4), 260-266.

S Kawai, K Nishio, S Nakamura, Y Sekido, T Niwa, N Hamajima (2005) Multiplex PCR with confronting twopair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T. 6(3), 346.

N Sunaga, T Kohno, N Yanagitani, H Sugimura, H Kunitoh, T Tamura (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. 11(8), 730-738.

L Xu, J Wain, D Miller, S Thurston, L Su, T Lynch (2001) The NAD (P) H: quinone Oxidoreductase 1 Gene Polymorphism and Lung Cancer Differential Susceptibility Based on Smoking Behavior. 10(4), 303-309.

Chun Chao, Zuo-Feng Zhang, Julien Berthiller, Paolo Boffetta, Mia Hashibe (2006) NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis. 15(5), 979-987.

C Bock, A Wenzlaff, M Cote, S Land, A Schwartz (2005) NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study. 26(2), 381-386.

L Bailey, N Roodi, C Verrier, C Yee, W Dupont, F Parl (1998) Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. 58(1), 65-70.

H Kawase, Nh, At, Kw, Ts, Kt (2003) Triplex Polymerase Chain Reactions with Confronting Two-Pair Primers (PCR-CTPP) for NQO1C609T, GSTM1and GSTT1Polymorphisms: a Convenient Genotyping Method. 4, 67-70.